期刊文献+

体内连续筛选法建立人结肠癌肝转移阶梯细胞模型 被引量:4

The establishment of stepwise metastatic colorectal carcinoma cell model to the liver via in vivo selection
暂未订购
导出
摘要 目的:通过在裸鼠体内进行SW1116结肠癌细胞株原位种植肝转移连续筛选,建立人结肠癌肝转移阶梯细胞模型系统,为研究结肠癌转移的分子机制提供实验模型。方法:将SW1116细胞株在裸鼠皮下连续5次传代后,取皮下种植瘤在裸鼠结肠进行原位种植,继而取肝脏转移灶进行下一代裸鼠结肠原位种植,经3次结肠原位种植肝转移筛选,建立大肠癌肝转移阶梯细胞模型。用免疫组化法验证种植瘤及转移灶的组织来源,并行同期体内外侵袭实验,检测经体内连续筛选出的癌细胞侵袭转移能力变化。结果:经5代皮下连续传代及3代结肠至肝的体内转移筛选,成功建立了第三代结肠癌肝转移筛选细胞系(CRCLM3)。裸鼠种植瘤及转移灶均表达人癌胚抗原,而同期体内外侵袭试验结果显示,经体内筛选得到的结肠癌细胞株转移能力逐渐加强。结论:经体内连续肝转移筛选所建立的结肠癌细胞系侵袭转移能力增强,而CRCLM3细胞系是研究结肠癌肝转移机制的理想细胞模型。 Objective To establish a stepwise metastatic cell line model of colorectal carcinoma to the liver via a consecutive in vivo selection with the SW1116 cell line, which would be used on the study of the molecular mechanism of metastasis of eolorectal carcinoma. Methods SW1116 cells were transplanted into the subcutis of nude mice and serially passaged for 5 times, then the subcutaneous tumor was implanted into the cecal wall of new nude mice. The liver metastastie lesions were picked out and implanted into the cecal wall of new nude mice; by implanting 3 times, stepwise metastatic colorectal carcinoma cell model was established by in vivo selection; The expression of human carcinoma antigen CEA in the subcutaneous tumor tissues, cecal tumor tissues and liver metastatic tissues were investigated by immunohistochemistry to prove that they were of human origin. In vivo and in vitro tests were performed to know the difference of its invasiveness and metastatic potential after in vivo selection. Results After 5 times of subcutaneous continuous passage and 3 screening process of consecutive hepatic metastases in vivo selection, the colorectal carcinoma liver metastasis selection 3(CRCLM3) cell line was established. Human carcinoembryonic antigen was detected in tumors from the nude mice. In vivo and in vitro tumor invasion and migration assay demonstrated that there was significant difference in the ability of invassiveness and metastatic potential in cell lines after in vivo selection. Conclusions CRCLM3 cell line could be established via consecutive in vivo selection with the SWlll6 cell line. The new cell line has stronger invasiveness and higher metastatic potential than the original SW1116 cell. The CRCLM3 cell model could be used on the study of the molecular mechanism of metastasis of colorectal carcinoma.
出处 《外科理论与实践》 2009年第6期633-638,共6页 Journal of Surgery Concepts & Practice
基金 国家自然科学基金课题(30772106)
关键词 大肠癌 原位种植 阶梯转移模型 SW1116细胞株 实验模型 Colorectal cancer Orthotopic implantation Stepwise metastasis model SW1116 cell line Experimental model
  • 相关文献

参考文献7

  • 1Moy KA, Yuan JM, Chung FL, et al. Urinary total isothiocyanates and colorectal cancer: a prospective study of men in Shanghai, China[J]. Cancer Epidemiol Biomarkers Prev,2008,17(6):1354-1359.
  • 2Kerr D. Clinical development of gene therapy for colorectal cancer[J]. Nat Rev Cancer,2003,3(8):615-622.
  • 3Li Y, Tian B, Yang J, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics[J]. J Cancer Res Clin Oneol,2004,130(8):460-468.
  • 4Townson JL, Chambers AF. Dormancy of solitary metastatic cells[J]. Cell Cycle,2006,5(16): 1744-1750.
  • 5Seymour K, Pettit S, O'Flaherty E, et al. Selection of metastatic tumour phenotypes by host immune systems[J]. Lancet, 1999,354(9194): 1989 - 1991.
  • 6Seki S, Kitada T, Kawada N, et al. Establishment and characteristics of human hepatocellular carcinoma cells with metastasis to lymph nodes[J]. Hepatogastroenterology, 1999,46(29):2812-2817.
  • 7Lee YG, Korenehuk S, Lehr J, et al. Establishment and characterization of a new human prostatic cancer cell line: DuCaP[J]. In Vivo,2001,15(2):157-162.

同被引文献28

  • 1张艳飞,刘莉,丁彦青.具有肝转移倾向的结肠癌细胞亚系的筛选与鉴定[J].南方医科大学学报,2007,27(2):126-130. 被引量:13
  • 2吴全,高枫,张森.雌激素及其受体对结直肠癌肝转移的影响[J].中华实验外科杂志,2007,24(3):367-367. 被引量:2
  • 3McCarty KS,Szabo E,Flowers JL,et al.Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.Cancer Res,1986,46:4244s-4248s.
  • 4Levy M,Visokai V,Lipska L,et al.Tumor markers in staging and prognosis of colorectal carcinoma.Neoplasma,2008,55:138-142.
  • 5Tsai WC,Jin JS,Chang WK,et al.Association of cortactin and fascin-1 expression in gastric adenocarcinoma:correlation with clinicopathological parameters.J Histochem Cytochem,2007,55:955-962.
  • 6Hofman P,Butori C,Havet K,et al.Prognostic significance of cortactin levels in head and neck squamous cell carcinoma:comparison with epidermal growth factor receptor status.Br J Cancer,2008,98:956-964.
  • 7Lee YY,Yu CP,Lin CK,et al.Expression of survivin and cortactin in colorectal adenocarcinoma:association with clinicopathological parameters.Dis Markers,2009,26:9-18.
  • 8Zhang LH,Tian B,Diao LR,et al.Dominant expression of 85 000 form of cortactin in colorectal cancer.J Cancer Res Clin Oncol,2006,132:113-120.
  • 9Weaver AM.Cortactin in tumor invasiveness.Cancer Lett,2008,265:157-166.
  • 10Anjomshoaa A,Lin YH,Black MA,et al.Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer.British Journal of Cancer,2008,99:966-973.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部